At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 9, 2026 at 08:09 ET
Novo Nordisk filed a routine 6-K updating its ongoing share repurchase program, reporting the repurchase of 890,000 B shares for approximately DKK 243.6 million between November 3-6, 2026. The filing contains no financial results or material corporate events.
- Novo Nordisk repurchased 890,000 B shares from November 3-6, 2026 at an average price of DKK 273.57 per share, totaling approximately DKK 243.6 million
- Total accumulated repurchases under the program initiated May 6, 2026: 27,845,000 B shares for DKK 8.008 billion
- Overall 12-month buyback program of up to DKK 15 billion began February 4, 2026; as of November 6, 2026, total repurchases were DKK 11.808 billion
- Company holds 56,644,876 B shares as treasury shares, representing 1.3% of total share capital of 4.465 billion shares
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access